Provided by Tiger Fintech (Singapore) Pte. Ltd.

Rafael Holdings, Inc.

2.12
+0.01000.47%
Post-market: 2.120.00000.00%16:34 EDT
Volume:25.21K
Turnover:53.39K
Market Cap:74.39M
PE:-1.00
High:2.16
Open:2.10
Low:2.10
Close:2.11
Loading ...

Company Profile

Company Name:
Rafael Holdings, Inc.
Exchange:
NYSE
Establishment Date:
2017
Employees:
30
Office Location:
520 Broad Street,Newark,New Jersey,United States
Zip Code:
07102
Fax:
- -
Introduction:
Rafael Holdings, Inc. primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. It operates in two segments, Healthcare and Real Estate. The company engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. Its lead drug candidate is CPI-613 (devimistat), currently under Phase III clinical study for the treatment of metastatic pancreatic cancer and acute myeloid leukemia. The company is also involved in developing Promitil, a molecule designed for the targeted delivery of mitomycin-C in a proprietary prodrug form, completed Phase 1B clinical studies; Folate-targeted Promitil (Promi-Fol) which is aimed at local treatment (intravesical) of superficial bladder cancer; and Promi-Dox, a highly potent dual drug liposome with MLP and doxorubicin targeting a potential basket of tumors. In addition, it engages in the development of surgical and procedural devices, including orthopedic arthroscopy instrumentation. Rafael Holdings, Inc. was incorporated in 2017 and is headquartered in Newark, New Jersey.

Directors

Name
Position
Howard S. Jonas
Chief Executive Officer, President,Executive Chairman
N. Scott Fine
Vice Chairman
Markus W. Sieger
Independent Director
Michael J. Weiss
Independent Director
Stephen Greenberg
Lead Independent Director
Mark Stein
Director
Susan Y. Bernstein
Director

Shareholders

Name
Position
Howard S. Jonas
Chief Executive Officer, President,Executive Chairman
David Polinsky
Chief Financial Officer and Principal Accounting Officer
John Goldberg
Chief Medical Officer